Latest news with #RecordatiIndustriaChimicaeFarmaceuticaSPA
Business Insider
4 days ago
- Business
- Business Insider
J.P. Morgan Reaffirms Their Buy Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
J.P. Morgan analyst James Gordon maintained a Buy rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report) today and set a price target of €67.00. The company's shares closed yesterday at €52.95. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Gordon is a 3-star analyst with an average return of 1.0% and a 51.01% success rate. Gordon covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Argenx Se. The word on The Street in general, suggests a Hold analyst consensus rating for Recordati Industria Chimica e Farmaceutica SPA with a €54.50 average price target.
Business Insider
4 days ago
- Business
- Business Insider
Kepler Capital Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Kepler Capital analyst Niccolo Guido Storer maintained a Hold rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report) on May 14 and set a price target of €55.50. The company's shares closed last Wednesday at €50.30. Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Guido Storer is a 5-star analyst with an average return of 16.6% and a 57.72% success rate. The word on The Street in general, suggests a Hold analyst consensus rating for Recordati Industria Chimica e Farmaceutica SPA with a €54.38 average price target, which is an 8.11% upside from current levels. In a report released on May 6, Deutsche Bank also maintained a Hold rating on the stock with a €55.00 price target.
Business Insider
01-06-2025
- Business
- Business Insider
Kepler Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
Kepler Capital analyst Niccolo Guido Storer maintained a Hold rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report) on May 30 and set a price target of €55.50. Confident Investing Starts Here: Guido Storer covers the Consumer Cyclical sector, focusing on stocks such as De'Longhi S.p.A., EssilorLuxottica SA, and Safilo Group SpA. According to TipRanks, Guido Storer has an average return of 15.2% and a 54.61% success rate on recommended stocks. In a report released on May 23, RBC Capital also maintained a Hold rating on the stock with a €55.50 price target. Based on Recordati Industria Chimica e Farmaceutica SPA's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €598.48 million and a net profit of €78.11 million. In comparison, last year the company earned a revenue of €526.16 million and had a net profit of €84.72 million
Business Insider
11-05-2025
- Business
- Business Insider
Recordati Industria Chimica e Farmaceutica SPA (0KBS) Gets a Hold from Kepler Capital
In a report released on May 9, Niccolo Guido Storer from Kepler Capital maintained a Hold rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS – Research Report), with a price target of €55.50. The company's shares closed last Friday at €52.23. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Guido Storer is ranked #741 out of 9472 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for Recordati Industria Chimica e Farmaceutica SPA with a €54.38 average price target, representing a 4.13% upside. In a report released on May 6, Deutsche Bank also maintained a Hold rating on the stock with a €55.00 price target. The company has a one-year high of €60.95 and a one-year low of €44.04. Currently, Recordati Industria Chimica e Farmaceutica SPA has an average volume of 24.22K.
